Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pattern recognition receptors (PRRs) sensing influenza virion components are a diverse group of innate immune sensors that detect specific viral motifs, known as pathogen-associated molecular patterns (PAMPs). Key members include Toll-like receptor 7 (TLR7), which recognizes viral single-stranded RNA (ssRNA) within endosomes (Diebold et al., 2004, Science), and Retinoic acid-inducible gene I (RIG-I), which detects 5-prime-triphosphorylated RNA in the cytosol (Pichlmair et al., 2006, Science). Other sensors like TLR3 detect double-stranded RNA (dsRNA) from infected cells, while the NLRP3 inflammasome is activated by the influenza M2 ion channel and PB1-F2 protein (Ichinohe et al., 2010, Nature Immunology). Activation of these receptors triggers signaling cascades involving IRF3/7 and NF-kappaB, leading to the production of Type I interferons and pro-inflammatory cytokines (Loo & Gale, 2011, Immunity). While these responses are vital for restricting viral replication, dysregulated or excessive PRR signaling is a primary driver of the "cytokine storm" associated with highly pathogenic influenza strains (Iwasaki & Pillai, 2014, Nature Reviews Immunology). Consequently, these receptors are targets for both antiviral adjuvants (agonists) and anti-inflammatory therapies (antagonists) to manage severe respiratory complications.
Agonism of endosomal or cytosolic sensors to stimulate innate antiviral immunity and interferon production; Antagonism of inflammasome or TLR signaling to mitigate immunopathology.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pattern recognition receptors sensing influenza virion components (PRRs (Influenza)).